Page last updated: 2024-11-01

nitroglycerin and Alzheimer Disease

nitroglycerin has been researched along with Alzheimer Disease in 1 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research Excerpts

ExcerptRelevanceReference
" Six of these articles concerning different topics (depression, tuberculosis detection, anticoagulation at home, cholinesterase inhibitors, insomnia and therapies, transdermal nitroglycerin and tendinopathies) are presented."4.83[Primary care in general internal medicine: relevant information in 2005]. ( Amstutz, V; Bodenmann, P; Favrat, B; Martin, S; Michaelis-Conus, K; Pasche, O, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodenmann, P1
Pasche, O1
Amstutz, V1
Martin, S1
Michaelis-Conus, K1
Favrat, B1

Reviews

1 review available for nitroglycerin and Alzheimer Disease

ArticleYear
[Primary care in general internal medicine: relevant information in 2005].
    Revue medicale suisse, 2006, Jan-25, Volume: 2, Issue:50

    Topics: Administration, Cutaneous; Administration, Oral; Alzheimer Disease; Anticoagulants; Cholinesterase I

2006